Published in Kidney Int on April 01, 1994
Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol (1995) 1.67
Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. Free Radic Biol Med (2010) 1.25
Dynamin activates NO production in rat renal inner medullary collecting ducts via protein-protein interaction with NOS1. Am J Physiol Renal Physiol (2011) 1.06
Autocrine inhibition of Na+/K(+)-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest (1995) 0.99
Asymmetric dimethylarginine, endothelial dysfunction and renal disease. Int J Mol Sci (2012) 0.99
Renal proximal tubular reabsorption is reduced in adult spontaneously hypertensive rats: roles of superoxide and Na+/H+ exchanger 3. Hypertension (2009) 0.97
PP2B-dependent NO production in the medullary thick ascending limb during diabetes. Am J Physiol Renal Physiol (2009) 0.95
Relationship between PPARalpha activation and NO on proximal tubular Na+ transport in the rat. BMC Pharmacol (2004) 0.92
Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest (2003) 0.90
K depletion enhances the extracellular Ca2+-induced inhibition of the apical K channels in the mTAL of rat kidney. J Gen Physiol (2002) 0.84
Nitric oxide produced by endothelial nitric oxide synthase promotes diuresis. Am J Physiol Regul Integr Comp Physiol (2010) 0.84
Expression of nitric oxide synthase isoforms in the mouse kidney: cellular localization and influence by lipopolysaccharide and Toll-like receptor 4. J Mol Histol (2006) 0.83
In vitro model of sepsis-induced renal epithelial reactive nitrogen species generation. Toxicol Sci (2010) 0.83
Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limb. J Clin Invest (1994) 0.82
Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS. J Physiol (2011) 0.82
Salt sensitivity of nitric oxide generation and blood pressure in mice with targeted knockout of the insulin receptor from the renal tubule. Am J Physiol Regul Integr Comp Physiol (2012) 0.79
Effects of thyroid hormone analogue and a leukotrienes pathway-blocker on renal ischemia/reperfusion injury in mice. BMC Nephrol (2011) 0.78
Cyclooxygenase 2, pS2, inducible nitric oxide synthase and transforming growth factor alpha in gastric adaptation to stress. World J Gastroenterol (2004) 0.75
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J (2010) 2.90
Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci U S A (1991) 2.44
Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol (1999) 1.95
Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes (2001) 1.81
Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int (1976) 1.77
Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene (2000) 1.76
Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med (1987) 1.76
The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes (1996) 1.72
Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci U S A (1987) 1.70
Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease. J Clin Invest (1975) 1.70
Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest (1997) 1.64
Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol (2000) 1.61
A natriuretic factor in the serum of patients with chronic uremia. J Clin Invest (1972) 1.59
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci U S A (1989) 1.54
Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis. Eur Respir Rev (2010) 1.51
Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum. J Clin Invest (1971) 1.50
Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis (1992) 1.47
Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int (1995) 1.42
Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int (1993) 1.35
Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol (1999) 1.34
In vitro assay for a humoral substance present during volume expansion and uraemia. Nature (1968) 1.30
Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis. Biochem Biophys Res Commun (2003) 1.27
Role of arginine in health and in renal disease. Am J Physiol (1994) 1.26
The peripheral metabolism of parathyroid hormone. N Engl J Med (1979) 1.26
Effects of chronic protein-calorie malnutrition on the kidney. Kidney Int (1973) 1.25
Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int (1988) 1.22
Selective uptake of intact parathyroid hormone by the liver: differences between hepatic and renal uptake. J Clin Invest (1976) 1.21
Renal infection in autosomal dominant polycystic kidney disease. Am J Med (1987) 1.20
Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect. J Pharmacobiodyn (1987) 1.18
Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am J Physiol Renal Physiol (2001) 1.18
Metabolic acidosis and parathyroidectomy increase Na+-H+ exchange in brush border vesicles. Am J Physiol (1983) 1.18
Mechanism of reduced glomerular filtration rate in chronic malnutrition. J Clin Invest (1980) 1.16
Effects of phosphate depletion and parathyroid hormone on renal glucose reabsorption. Am J Physiol (1974) 1.15
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension. Eur Respir J (2010) 1.13
Increased stress protein ORP150 autoantibody production in Type 1 diabetic patients. Diabet Med (2006) 1.13
Cyclic nucleotides in bone and mineral metabolism. Adv Cyclic Nucleotide Res (1979) 1.12
Involvement of the homeodomain-containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription. Biochem Biophys Res Commun (1996) 1.11
Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats. Eur Respir J (2010) 1.10
Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol (1996) 1.09
Circulating fibrocytes and pulmonary arterial hypertension. Eur Respir J (2012) 1.09
Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension. Eur Respir J (2009) 1.08
Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci U S A (1985) 1.07
Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int (1994) 1.07
Differences between women and men with chronic renal disease. Nephrol Dial Transplant (1998) 1.05
Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin Nephrol (1998) 1.05
Inhibitory effects of hypermagnesemia on the renal action of parathyroid hormone. J Clin Invest (1976) 1.05
Degradation of parathyroid hormone and fragment production by the isolated perfused dog kidney. The effect of glomerular filtration rate and perfusate CA++ concentrations. J Clin Invest (1977) 1.03
Malabsorption in the tropics: a second look. I. The role of protein malnutrition. Am J Clin Nutr (1967) 1.03
Use of computerized tomography to diagnose complications of percutaneous renal biopsy. Kidney Int (1978) 1.02
Effects of nephron reduction and dietary protein content on renal ammoniagenesis in the rat. Kidney Int (1975) 1.02
Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol (1996) 1.01
Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone. J Clin Invest (1979) 1.01
Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia. Jpn J Pharmacol (1990) 1.00
Reticuloendothelial and mesangial function in murine immune complex glomerulonephritis. Kidney Int (1979) 1.00
Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Diabetologia (2004) 1.00
Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int (1996) 0.99
Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats. Thromb Res (1982) 0.98
Inhibition by ammonium of sodium transport across isolated toad bladder. Am J Physiol (1971) 0.98
Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis. Am J Physiol (1999) 0.97
Renal function in patients with cystic fibrosis. J Pediatr (1971) 0.97
Response of deep nephrons and the terminal collecting duct to a reduction in renal mass. Am J Physiol (1979) 0.97
Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells. J Clin Invest (1991) 0.97
The functional adaptation of the diseased kidney. 3. Ammonium excretion. J Clin Invest (1966) 0.97
Selective uptake of the synthetic amino terminal fragment of bovine parathyroid hormone by isolated perfused bone. J Clin Invest (1978) 0.97
Production of thromboxane A2 by the kidney in glycerol-induced acute renal failure in the rabbit. Prostaglandins (1980) 0.97
Nephrosclerosis postpartum and in women taking oral contraceptives. Arch Intern Med (1976) 0.96
Effects of dinitrophenol and oligomycin on the coupling between anaerobic metabolism and anaerobic sodium transport by the isolated turtle bladder. J Gen Physiol (1966) 0.96
New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis (1991) 0.96
Impaired parathyroid hormone metabolism in patients with chronic renal failure. N Engl J Med (1978) 0.96
The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis. Eur Respir J (2010) 0.95
Increased Na+-H+ exchange in brush border vesicles from dogs with renal failure. Am J Physiol (1982) 0.95
Lack of a direct effect of 1,25-dihydroxycholecalciferol on parathyroid hormone secretion by normal bovine parathyroid glands. Endocrinology (1980) 0.95
Regulation of renal Na+-K+-ATPase in the rat by adrenal steroids. Am J Physiol (1981) 0.95
A humoral inhibitor of sodium transport in uremic serum. A potential toxin? Arch Intern Med (1970) 0.95
Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney Int (1997) 0.94
TGF-beta1 triggers oxidative modifications and enhances apoptosis in HIT cells through accumulation of reactive oxygen species by suppression of catalase and glutathione peroxidase. Free Radic Biol Med (1997) 0.94
Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases. Respiration (2007) 0.94
Effects of reduced renal mass and dietary protein intake on amino acid release and glucose uptake by rat muscle in vitro. J Clin Invest (1979) 0.94
Effects of acute bilateral ureteral obstruction on deep nephron and terminal collecting duct function in the young rat. J Clin Invest (1977) 0.94
Bone disease in long-term dialysis. Am J Kidney Dis (1996) 0.94
Pathophysiology of obstructive nephropathy. Kidney Int (1983) 0.94
Pseudohypoparathyroidism type II: restoration of normal renal responsiveness to parathyroid hormone by calcium administration. J Clin Endocrinol Metab (1974) 0.94
Diffuse bilateral cortical necrosis; a longitudinal study of the functional characteristics of residual nephrons. Am J Med (1967) 0.93
Inhibition of glycolysis by ethacrynic acid and furosemide. Am J Physiol (1971) 0.93
Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin. J Clin Invest (1990) 0.93
Evaluation of gut motility in type II diabetes by the radiopaque marker method. J Gastroenterol Hepatol (2000) 0.93
Collagen-induced release of interleukin 1 from human blood mononuclear cells. Potentiation by fibronectin binding to the alpha 5 beta 1 integrin. J Clin Invest (1992) 0.92
Effects of acetazolamide on the urinary excretion of cyclic AMP and on the activity of renal adenyl cyclase. J Clin Invest (1974) 0.92
Pharmacologic studies on analgesics. VII. Significance of the calcium ion in morphine analgesia. J Pharmacol Exp Ther (1966) 0.91
Effects of probucol on renal function in rats with bilateral ureteral obstruction. Kidney Int (1990) 0.91
Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am J Kidney Dis (1990) 0.90
Renal cortical release of a specific macrophage chemoattractant in response to ureteral obstruction. Lab Invest (1990) 0.90